Patent Yard Sign in
Canadian application, no grantCanada

Substituted aminomethyl isoxazoline derivatives useful as antimicrobials

CA 2318762 A1 · Owner: Morris, Joel · Inventors: Barbachyn, Michael Robert; Wishka, Donn G.; Thomas, Richard Charles

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides novel substituted aminoheteroaromatic isoxazoline derivatives of formula (I) wherein R1 is H, alkyl, cycloalkyl, alkoxy amino, or alkylamino; Y is H, F, or CH3; W is O or S; Ring P is a 5-, membered heteroaromatic moiety having one to three atoms selected from the group consisting of sulfur, nitrogen and oxygen atoms wherein the 5-membered , heteroaromatic moiety can additionally have a fused-on benzene or naphthyl a , 6-membered heteroaromatic moiety having at least one nitrogen atom wherein , the 6-membered heteroaromatic moiety can additionally have a fused-on benzene naphthyl or 5-membered heteroaromatic moiety having one to three atoms selected from …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 10, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 10, 2019.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 10, 2021.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 10, 1999
GrantedNo grant recorded
Term endedFebruary 10, 2019
Patent numberCA 2318762 A1
Classification (IPC)C07D413/14 +2 more

Timeline

Timeline From CIPO dates

2000200220042006200820102012201420162018Application filedFeb 10, 1999Term endedFeb 10, 2019

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.